ÂÜÀòÂÒÂ×

Ambaw has 22 years of experience with the last 13 years in multiple senior executive roles in the medical device and pharmaceutical industry across multiple specialty therapeutic areas such as immunology and oncology. Senior leadership positions have been across multiple brands with responsibility for development and commercialization including full P&L responsibility for a $700 million multi-product portfolio business across multiple global geographies. This also includes being involved in the launch of over twenty products including Camptosar®, Detrol®, Framin®, Lovenox®, Taxotere®, and Celebrex®. Ambaw has held senior executive roles at MCS Inc., Sanofi and Pfizer. He has a B.S. in Biology and Chemistry from MSU and has completed advanced executive education certificate programs at Kellogg School of Business at Northwestern University, Harvard Business School and at the Wharton School of Business at the University of Pennsylvania.